A Randomized, Placebo-controlled, Double-blinded Study With GB-0998 for Unexplained Primary Recurrent Miscarriage
Phase of Trial: Phase III
Latest Information Update: 10 Mar 2017
At a glance
- Drugs Immunoglobulin G (Primary)
- Indications Spontaneous abortion
- Focus Registrational; Therapeutic Use
- Sponsors Japan Blood Products Organization
- 06 Mar 2017 Planned End Date changed from 1 Jun 2017 to 1 Jun 2019.
- 06 Mar 2017 Planned primary completion date changed from 1 Feb 2017 to 1 Feb 2019.
- 24 Jul 2014 New trial record